# Travelers Companies, Inc.: financial statements, quarterly

TRV · NYSE · CIK 86312 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/trv.md) · [Financials](/companies/trv/financials.md) · [Filings](/companies/trv/filings.md) · [Insiders](/companies/trv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/trv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [10.9 d](/filings/0000086312-26-000065.md) | [11.2](/filings/0000086312-25-000029.md) | [11.3](/filings/0000086312-25-000047.md) | [11.9](/filings/0000086312-25-000069.md) | [12.0 d](/filings/0000086312-26-000065.md) | [11.8](/filings/0000086312-26-000111.md) | [12.1](/filings/0000086312-26-000145.md) | [12.5](/filings/0000086312-26-000181.md) | [12.4 d](/filings/0000086312-26-000065.md) | [11.9](/filings/0000086312-26-000111.md) | [12.2](/filings/0000086312-26-000145.md) | [12.4](/filings/0000086312-26-000181.md) |
| Selling, general and administrative | $bn | [1.3 d](/filings/0000086312-26-000065.md) | [1.4](/filings/0000086312-25-000029.md) | [1.5](/filings/0000086312-25-000047.md) | [1.5](/filings/0000086312-25-000069.md) | [1.5 d](/filings/0000086312-26-000065.md) | [1.5](/filings/0000086312-26-000111.md) | [1.5](/filings/0000086312-26-000145.md) | [1.6](/filings/0000086312-26-000181.md) | [1.5 d](/filings/0000086312-26-000065.md) | [1.5](/filings/0000086312-26-000111.md) | [1.6](/filings/0000086312-26-000145.md) | [1.6](/filings/0000086312-26-000181.md) |
| Operating income | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $bn | [0.1 d](/filings/0000086312-26-000065.md) | [0.1](/filings/0000086312-25-000029.md) | [0.1](/filings/0000086312-25-000047.md) | [0.1](/filings/0000086312-25-000069.md) | [0.1 d](/filings/0000086312-26-000065.md) | [0.1](/filings/0000086312-26-000111.md) | [0.1](/filings/0000086312-26-000145.md) | [0.1](/filings/0000086312-26-000181.md) | [0.1 d](/filings/0000086312-26-000065.md) | [0.1](/filings/0000086312-26-000111.md) | [0.1](/filings/0000086312-26-000145.md) | [0.1](/filings/0000086312-26-000181.md) |
| Income tax | $bn | [0.4 d](/filings/0000086312-26-000065.md) | [0.2](/filings/0000086312-25-000029.md) | [0.1](/filings/0000086312-25-000047.md) | [0.3](/filings/0000086312-25-000069.md) | [0.5 d](/filings/0000086312-26-000065.md) | [0.1](/filings/0000086312-26-000111.md) | [0.4](/filings/0000086312-26-000145.md) | [0.5](/filings/0000086312-26-000181.md) | [0.6 d](/filings/0000086312-26-000065.md) | [0.4](/filings/0000086312-26-000111.md) | [0.6](/filings/0000086312-26-000145.md) | [0.5](/filings/0000086312-26-000181.md) |
| Net income | $bn | [1.6 d](/filings/0000086312-26-000065.md) | [1.1](/filings/0000086312-25-000029.md) | [0.5](/filings/0000086312-25-000047.md) | [1.3](/filings/0000086312-25-000069.md) | [2.1 d](/filings/0000086312-26-000065.md) | [0.4](/filings/0000086312-26-000111.md) | [1.5](/filings/0000086312-26-000145.md) | [1.9](/filings/0000086312-26-000181.md) | [2.5 d](/filings/0000086312-26-000065.md) | [1.7](/filings/0000086312-26-000111.md) | [2.2](/filings/0000086312-26-000145.md) | [1.9](/filings/0000086312-26-000181.md) |
| Diluted EPS | $ per share | not reported | [4.80](/filings/0000086312-25-000029.md) | [2.29](/filings/0000086312-25-000047.md) | [5.42](/filings/0000086312-25-000069.md) | not reported | [1.70](/filings/0000086312-26-000111.md) | [6.53](/filings/0000086312-26-000145.md) | [8.24](/filings/0000086312-26-000181.md) | not reported | [7.78](/filings/0000086312-26-000111.md) | [10.26](/filings/0000086312-26-000145.md) | [9.04](/filings/0000086312-26-000181.md) |
| Basic EPS | $ per share | not reported | [4.87](/filings/0000086312-25-000029.md) | [2.32](/filings/0000086312-25-000047.md) | [5.50](/filings/0000086312-25-000069.md) | not reported | [1.73](/filings/0000086312-26-000111.md) | [6.63](/filings/0000086312-26-000145.md) | [8.37](/filings/0000086312-26-000181.md) | not reported | [7.89](/filings/0000086312-26-000111.md) | [10.41](/filings/0000086312-26-000145.md) | [9.20](/filings/0000086312-26-000181.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.7](/filings/0000086312-25-000012.md) | [0.7](/filings/0000086312-24-000032.md) | [0.7](/filings/0000086312-24-000051.md) | [0.8](/filings/0000086312-24-000059.md) | [0.7](/filings/0000086312-26-000065.md) | [0.7](/filings/0000086312-25-000029.md) | [0.7](/filings/0000086312-25-000047.md) | [0.7](/filings/0000086312-25-000069.md) | [0.8](/filings/0000086312-26-000181.md) | [0.6](/filings/0000086312-26-000111.md) | [0.6](/filings/0000086312-26-000145.md) | [0.8](/filings/0000086312-26-000181.md) |
| Total assets | $bn | [126](/filings/0000086312-25-000012.md) | [127](/filings/0000086312-24-000032.md) | [129](/filings/0000086312-24-000051.md) | [135](/filings/0000086312-24-000059.md) | [133](/filings/0000086312-26-000065.md) | [136](/filings/0000086312-25-000029.md) | [139](/filings/0000086312-25-000047.md) | [144](/filings/0000086312-25-000069.md) | [144](/filings/0000086312-26-000181.md) | [142](/filings/0000086312-26-000111.md) | [144](/filings/0000086312-26-000145.md) | [142](/filings/0000086312-26-000181.md) |
| Total liabilities | $bn | [101](/filings/0000086312-25-000012.md) | [102](/filings/0000086312-24-000032.md) | [104](/filings/0000086312-24-000051.md) | [107](/filings/0000086312-24-000059.md) | [105](/filings/0000086312-26-000065.md) | [108](/filings/0000086312-25-000029.md) | [109](/filings/0000086312-25-000047.md) | [112](/filings/0000086312-25-000069.md) | [111](/filings/0000086312-26-000181.md) | [110](/filings/0000086312-26-000111.md) | [110](/filings/0000086312-26-000145.md) | [113](/filings/0000086312-26-000181.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.1](/filings/0000086312-25-000012.md) | not reported | not reported | not reported | [0.1](/filings/0000086312-26-000065.md) | not reported | not reported | not reported | [0.3](/filings/0000086312-26-000065.md) | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.1](/filings/0000086312-25-000012.md) | not reported | not reported | not reported | [0.1](/filings/0000086312-26-000065.md) | not reported | not reported | not reported | [0.1](/filings/0000086312-26-000065.md) | not reported | not reported | not reported |
| Shareholders' equity | $bn | [24.9](/filings/0000086312-26-000065.md) | [25.0](/filings/0000086312-25-000029.md) | [24.9](/filings/0000086312-25-000047.md) | [27.7](/filings/0000086312-25-000069.md) | [27.9](/filings/0000086312-26-000065.md) | [28.2](/filings/0000086312-26-000111.md) | [29.5](/filings/0000086312-26-000145.md) | [31.6](/filings/0000086312-26-000181.md) | [32.9](/filings/0000086312-26-000181.md) | [32.0](/filings/0000086312-26-000111.md) | [33.1](/filings/0000086312-26-000145.md) | [29.0](/filings/0000086312-26-000181.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,104 d](/filings/0000086312-26-000065.md) | [1,458](/filings/0000086312-25-000029.md) | [1,677 d](/filings/0000086312-25-000047.md) | [3,875 d](/filings/0000086312-25-000069.md) | [2,064 d](/filings/0000086312-26-000065.md) | [1,360](/filings/0000086312-26-000111.md) | [2,334 d](/filings/0000086312-26-000145.md) | [4,227 d](/filings/0000086312-26-000181.md) | [2,685 d](/filings/0000086312-26-000065.md) | [2,198](/filings/0000086312-26-000111.md) | [1,916 d](/filings/0000086312-26-000145.md) | [3,878 d](/filings/0000086312-26-000181.md) |
| Dividends paid | $m | [232 d](/filings/0000086312-26-000065.md) | [229](/filings/0000086312-25-000029.md) | [244 d](/filings/0000086312-25-000047.md) | [238 d](/filings/0000086312-25-000069.md) | [240 d](/filings/0000086312-26-000065.md) | [240](/filings/0000086312-26-000111.md) | [250 d](/filings/0000086312-26-000145.md) | [247 d](/filings/0000086312-26-000181.md) | [242 d](/filings/0000086312-26-000065.md) | [237](/filings/0000086312-26-000111.md) | [263 d](/filings/0000086312-26-000145.md) | [259 d](/filings/0000086312-26-000181.md) |
| Share repurchases | $m | [64.0 d](/filings/0000086312-26-000065.md) | [250](/filings/0000086312-25-000029.md) | [249 d](/filings/0000086312-25-000047.md) | [248 d](/filings/0000086312-25-000069.md) | [256 d](/filings/0000086312-26-000065.md) | [250](/filings/0000086312-26-000111.md) | [500 d](/filings/0000086312-26-000145.md) | [619 d](/filings/0000086312-26-000181.md) | [1,635 d](/filings/0000086312-26-000065.md) | [1,785](/filings/0000086312-26-000111.md) | [1,313 d](/filings/0000086312-26-000145.md) | [1,487 d](/filings/0000086312-26-000181.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [234](/filings/0000086312-24-000032.md) | [230](/filings/0000086312-24-000051.md) | [231](/filings/0000086312-24-000059.md) | [232](/filings/0000086312-25-000029.md) | [232](/filings/0000086312-25-000047.md) | [231](/filings/0000086312-25-000069.md) | [230](/filings/0000086312-26-000111.md) | [229](/filings/0000086312-26-000145.md) | [228](/filings/0000086312-26-000181.md) | [218](/filings/0000086312-26-000111.md) | [214](/filings/0000086312-26-000145.md) | [211](/filings/0000086312-26-000181.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 204,946,347 at 2026-10-09, from the cover of the [10-Q filed 2026-10-16](/filings/0000086312-26-000181.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.